Following on from the success of the Immunogenicity event last year, SMi announces their 2nd annual Immunogenicity conference on 29-30 June 2015 in London, UK

LONDON, UNITED KINGDOM, May 19, 2015 /EINPresswire.com/ -- Understanding Immunogenicity is a key challenge in the development of therapeutics with many biologics inducing undesirable immune responses directed towards the therapeutic resulting in reduced efficacy, anaphylaxis and occasionally life threatening autoimmunity. SMi’s Immunogenicity conference will explore the latest updates on the prediction and reduction of immunogenicity, clinical results and interpretations and optimising bioassays.

SMi are delighted to announce that UCB will be speaking at the event and will have 2 presentations on Immunological tolerance and Peptide immunotherapy.

Presented by Farnaz Fallah-Arani, Group Leader, Pharmacology at UCB, her presentation entitled achieving immunological tolerance – are we there yet, will look at topics such as; can immunological tolerance be achieved clinically?; Pro’s and Con’s of in vitro and in vivo assays of modelling immunological tolerance pre-clinically will be discussed and how well do these pre-clinical models translate into the clinic.

Additionally Emma Smith, Senior Group Leader, UCB, will present on Peptide immunotherapy for the treatment of autoimmune disease – closer to a cure and will look at topics such as; why peptide immunotherapy over conventional treatments?; peptide immunotherapy in preclinical models and translating efficacy from preclinical models into the clinic.

For more information or to download UCB full presentations visit the website

In addition to the event, there will be an interactive workshop taking place on the 1st July entitled: Tools for early immunogenicity risk assessment and reduction, hosted by Sofie Pattijn, CTO, ImmunXperts SA and Morten Nielsen, Associate Professor, Center for Biological Sequence Analysis, Technical University of Denmark

A brochure with a full list of speakers and presentations is available to download online. For further information or to book a place, visit www.immuno.co.uk/EIN

Delegate enquiries: Contact Frederick Agboletey on +44 (0)20 7827 6070 or email: fagboletey@smi-online.co.uk
Immunogenicity 2015 is proudly sponsored by: SQI Diagnostics

2nd Annual Immunogenicity conference
29th & 30th June 2015
Marriott Regents Park Hotel, London, UK
www.immuno.co.uk/EIN

--------------- END ---------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

sam mahoney
SMi Group Ltd
+442078276000
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.